協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/04 | 2,832 | 2,838 | 2,757 | 2,768 | -83 | -2.9% | 981,500 |
| 2022/03/03 | 2,870 | 2,874 | 2,823 | 2,851 | -15 | -0.5% | 676,200 |
| 2022/03/02 | 2,898 | 2,906 | 2,859 | 2,866 | -56 | -1.9% | 810,400 |
| 2022/03/01 | 2,990 | 3,005 | 2,912 | 2,922 | -32 | -1.1% | 1,047,100 |
| 2022/02/28 | 2,916 | 2,972 | 2,914 | 2,954 | +33 | +1.1% | 1,079,200 |
| 2022/02/25 | 2,947 | 2,958 | 2,896 | 2,921 | -14 | -0.5% | 667,100 |
| 2022/02/24 | 2,995 | 3,000 | 2,910 | 2,935 | -95 | -3.1% | 1,073,900 |
| 2022/02/22 | 3,040 | 3,045 | 2,980 | 3,030 | -20 | -0.7% | 689,300 |
| 2022/02/21 | 3,015 | 3,060 | 2,985 | 3,050 | -20 | -0.7% | 979,200 |
| 2022/02/18 | 3,190 | 3,190 | 3,040 | 3,070 | +20 | +0.7% | 1,170,200 |
| 2022/02/17 | 3,090 | 3,115 | 3,005 | 3,050 | -35 | -1.1% | 1,219,600 |
| 2022/02/16 | 2,970 | 3,095 | 2,940 | 3,085 | +148 | +5% | 1,420,600 |
| 2022/02/15 | 2,921 | 2,944 | 2,907 | 2,937 | +49 | +1.7% | 746,000 |
| 2022/02/14 | 2,973 | 2,980 | 2,864 | 2,888 | -84 | -2.8% | 719,800 |
| 2022/02/10 | 2,935 | 2,988 | 2,934 | 2,972 | +69 | +2.4% | 1,075,800 |
| 2022/02/09 | 2,906 | 2,930 | 2,860 | 2,903 | -34 | -1.2% | 1,318,900 |
| 2022/02/08 | 2,960 | 3,015 | 2,911 | 2,937 | +14 | +0.5% | 1,445,700 |
| 2022/02/07 | 2,920 | 2,938 | 2,871 | 2,923 | +27 | +0.9% | 729,200 |
| 2022/02/04 | 2,888 | 2,925 | 2,870 | 2,896 | -14 | -0.5% | 848,600 |
| 2022/02/03 | 2,909 | 2,924 | 2,883 | 2,910 | -9 | -0.3% | 652,100 |
| 2022/02/02 | 2,863 | 2,928 | 2,863 | 2,919 | +65 | +2.3% | 657,800 |
| 2022/02/01 | 2,874 | 2,908 | 2,844 | 2,854 | -1 | ±0% | 725,900 |
| 2022/01/31 | 2,880 | 2,880 | 2,836 | 2,855 | -10 | -0.3% | 1,029,500 |
| 2022/01/28 | 2,865 | 2,904 | 2,852 | 2,865 | +28 | +1% | 756,500 |
| 2022/01/27 | 2,907 | 2,908 | 2,817 | 2,837 | -72 | -2.5% | 912,400 |
| 2022/01/26 | 2,918 | 2,942 | 2,889 | 2,909 | -1 | ±0% | 532,200 |
| 2022/01/25 | 2,901 | 2,931 | 2,887 | 2,910 | -41 | -1.4% | 1,282,000 |
| 2022/01/24 | 2,907 | 2,964 | 2,894 | 2,951 | +35 | +1.2% | 624,600 |
| 2022/01/21 | 2,893 | 2,929 | 2,844 | 2,916 | -9 | -0.3% | 708,400 |
| 2022/01/20 | 2,844 | 2,957 | 2,844 | 2,925 | +86 | +3% | 1,026,900 |
| 2022/01/19 | 2,889 | 2,913 | 2,826 | 2,839 | -84 | -2.9% | 805,400 |
| 2022/01/18 | 2,966 | 2,985 | 2,920 | 2,923 | -43 | -1.4% | 517,400 |
| 2022/01/17 | 2,954 | 3,005 | 2,943 | 2,966 | +28 | +1% | 638,200 |
| 2022/01/14 | 2,950 | 2,950 | 2,909 | 2,938 | -102 | -3.4% | 1,302,100 |
| 2022/01/13 | 3,095 | 3,110 | 3,030 | 3,040 | -100 | -3.2% | 746,700 |
| 2022/01/12 | 3,095 | 3,170 | 3,080 | 3,140 | +50 | +1.6% | 765,800 |
| 2022/01/11 | 3,015 | 3,105 | 3,000 | 3,090 | +25 | +0.8% | 1,077,800 |
| 2022/01/07 | 3,090 | 3,110 | 3,045 | 3,065 | -25 | -0.8% | 919,500 |
| 2022/01/06 | 3,175 | 3,185 | 3,090 | 3,090 | -105 | -3.3% | 819,900 |
| 2022/01/05 | 3,185 | 3,205 | 3,150 | 3,195 | +5 | +0.2% | 497,300 |
| 2022/01/04 | 3,200 | 3,200 | 3,155 | 3,190 | +55 | +1.8% | 439,200 |
| 2021/12/30 | 3,145 | 3,175 | 3,125 | 3,135 | -25 | -0.8% | 458,700 |
| 2021/12/29 | 3,165 | 3,200 | 3,135 | 3,160 | -55 | -1.7% | 420,800 |
| 2021/12/28 | 3,200 | 3,225 | 3,190 | 3,215 | +30 | +0.9% | 457,900 |
| 2021/12/27 | 3,200 | 3,205 | 3,170 | 3,185 | -20 | -0.6% | 309,600 |
| 2021/12/24 | 3,225 | 3,235 | 3,195 | 3,205 | -15 | -0.5% | 245,000 |
| 2021/12/23 | 3,210 | 3,230 | 3,185 | 3,220 | +20 | +0.6% | 318,500 |
| 2021/12/22 | 3,215 | 3,220 | 3,180 | 3,200 | -10 | -0.3% | 374,900 |
| 2021/12/21 | 3,170 | 3,230 | 3,170 | 3,210 | +50 | +1.6% | 484,900 |
| 2021/12/20 | 3,150 | 3,200 | 3,145 | 3,160 | -45 | -1.4% | 459,900 |
851～
900
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
